Both Surgical Site Infections (SSIs) and Healthcare Acquired Infections (HCAIs) demand a coordinated approach pre-and post-surgery by healthcare professionals and their patients.
Hibiwash® is your trusted partner in helping prevent infections, promote skin’s integrity and save time before performing or undergoing surgical procedures.

Everything you need. Nothing you don't.

The new and improved Hibiwash is reformulated to remove unnecessary additives, helping to minimise skin irritation, while maintaining antimicrobial performance when used as directed.

Why Hibiwash

  • Broad antimicrobial efficacy

    Effective against a wide range of microbes including several strains of Gram positive and Gram negative bacteria, yeast, fungi and viruses1,2,3.

  • Long-lasting protection

    Hibiwash is not absorbed into the skin but binds to it, forming a protective layer even after rinsing, and efficiently kills bacteria for several hours after application4, 5,6,7,8.

  • Caring for skin

    Dermatologically tested and enhanced with emollients. Free from dyes, fragrances and soya oil — reducing risk of irritation6,10.

  • Proven efficacy

    Contains 4% chlorhexidine gluconate, a well‑established antiseptic active ingredient, supporting hygiene practices when used according to approved indications

  • Easy to use

    Designed for patients to use before and after elective surgery. Available in 125ml, 250ml, 500ml and 5L sizes.

  • HCP training & support

    In-house and on-ward training, marketing materials and clinical data available from your Mölnlycke representative.

  • Healthcare professionals should also provide patients with appropriate instructions on the use of Hibiwash for pre-operative and post-operative skin antisepsis, in accordance with the approved SPC.

Contact Us

To request more information on Hibiwash or to connect with a Mölnlycke representative, please complete the form below and a member of the team will be in touch with you shortly.

You must be logged in to submit this form. If you are logged in and still cannot post, make sure "Do not track" in your browser settings is disabled.

References

  • 1. Garibaldi RA. Journal of Hospital Infection 1988; 11: 5-9

    2. Menon, V. Chapter 22 Sixth Edition 2021; Pages 477-506

    3. Jarral O et all 2011

    4. Sheikh W. Current Therapeutic Research 1986;40(6): 1096-1102

    5. Faoagali et al. American Journal of Infection Control 2 1995

    6. Case DE., Chlorhexidine: Attempt to detect percutaneous absorption in man, Proceedings of the 9th International Congress of Chemotherapy, J.D. Williams & A.M. Geddes ED., 1976;3 (Chemotherapy): 367-374.

    7. Mölnlycke Health Care. Internal Report REPR0495. Data on file

    8. Tanner J et al. A fresh look at perioperative body washing. Journal of Infection Prevention. 2012; (13) 11 - 15.

    9. Molnlycke Internal Report REPR0781 (patch test study)

Select country

Get knowledge, learn about our products, get support and more.

United Kingdom

No markets

Find jobs, our financial reports and more.

Mölnlycke corporate

Are you a healthcare professional?

This webpage contains information that is only intended for healthcare professionals. By selecting ‘Yes, I am’ you confirm that you are a healthcare professional.

No, I am not a Health Care Professional